Appendicitis among liver transplant recipients has not been described in the current literature. We report 8 recipients who experienced appendicitis three weeks to 181 months after liver transplantation (LT). Initial presenting findings differed from the nonimmunosuppressed population in that a majo
Visceral leishmaniasis among liver transplant recipients: An overview
✍ Scribed by Isabel Campos-Varela; Oscar Len; Lluís Castells; Natalia Tallada; Esteban Ribera; Cristina Dopazo; Víctor Vargas; Joan Gavaldà; Ramón Charco
- Publisher
- John Wiley and Sons
- Year
- 2008
- Tongue
- English
- Weight
- 178 KB
- Volume
- 14
- Category
- Article
- ISSN
- 1527-6465
- DOI
- 10.1002/lt.21538
No coin nor oath required. For personal study only.
✦ Synopsis
There has been an increase in the incidence of visceral leishmaniasis (VL), especially among hemopoietic and renal transplant recipients. [1][2][3] Remarkably, very few cases have been described among liver transplant recipients. We report a case of VL in a liver transplant recipient and analyze the other 9 cases published in the literature. 3-
📜 SIMILAR VOLUMES
Andrea DiMartini and her colleagues have provided prospectively gathered data on the course of alcohol use among liver transplant recipients during the first 5 years of postgraft living. Having worked with the difficult issue of alcohol use disorders and liver transplantation for a number of years n
Segmental liver transplantation with living donor (LD), reduced cadaveric (Reduced), and split cadaveric (Split) allografts has expanded the availability of size-appropriate organs for pediatric recipients. The relevance of recipient age to the selection of graft type has not been fully explored, bu
A vast majority of the transplant recipients are cytomegalovirus (CMV)-seropositive (R+). We sought to assess variables predictive of CMV infection, specifically in R+ liver transplant recipients. Study patients comprised 182 consecutive liver transplant recipients who survived at least 14 days afte
Vancomycin-resistant Enterococcus faecium (VREF) has become a significant nosocomial pathogen for immunosuppressed patients. During a 5-month period in 1993, 8 cases of invasive infection with VREF (7 with bacteremia) were identified in liver transplant recipients, half of whom were adults. Epidemio
Toxoplasmosis is a serious and potentially life-threatening disease in liver transplant recipients while they are immunosuppressed. We report the clinical and laboratory findings related to active toxoplasma infection associated with 40 immunosuppressed liver transplant procedures that took place ov